Posted by: admin on: September 19, 2011
In new guidelines from the European Society of Cardiology (ESC), Prasugrel – a once daily oral antiplatelet medicine – received a Class I recommendation for use in patients undergoing percutaneous coronary intervention (PCI) after experiencing a non-ST-segment elevation acute coronary syndrome (which comprises non-ST segment elevation myocardial infarction or NSTEMI – a type of heart […]